Logo image of KIN.BR

KINEPOLIS (KIN.BR) Stock Fundamental Analysis

EBR:KIN - Euronext Brussels - BE0974274061 - Common Stock - Currency: EUR

35.65  +0.05 (+0.14%)

Fundamental Rating

4

KIN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 45 industry peers in the Entertainment industry. KIN has a medium profitability rating, but doesn't score so well on its financial health evaluation. KIN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year KIN was profitable.
In the past year KIN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: KIN reported negative net income in multiple years.
KIN had a positive operating cash flow in 4 of the past 5 years.
KIN.BR Yearly Net Income VS EBIT VS OCF VS FCFKIN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

The Return On Assets of KIN (3.54%) is better than 71.11% of its industry peers.
The Return On Equity of KIN (17.91%) is better than 82.22% of its industry peers.
KIN has a better Return On Invested Capital (7.04%) than 73.33% of its industry peers.
KIN had an Average Return On Invested Capital over the past 3 years of 6.76%. This is below the industry average of 10.04%.
The last Return On Invested Capital (7.04%) for KIN is above the 3 year average (6.76%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.54%
ROE 17.91%
ROIC 7.04%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
KIN.BR Yearly ROA, ROE, ROICKIN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

Looking at the Profit Margin, with a value of 7.00%, KIN is in the better half of the industry, outperforming 75.56% of the companies in the same industry.
KIN's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 14.20%, KIN belongs to the best of the industry, outperforming 82.22% of the companies in the same industry.
KIN's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 24.01%, KIN is not doing good in the industry: 91.11% of the companies in the same industry are doing better.
KIN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.2%
PM (TTM) 7%
GM 24.01%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
KIN.BR Yearly Profit, Operating, Gross MarginsKIN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

2

2. Health

2.1 Basic Checks

KIN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for KIN remains at a similar level compared to 1 year ago.
The number of shares outstanding for KIN has been increased compared to 5 years ago.
Compared to 1 year ago, KIN has an improved debt to assets ratio.
KIN.BR Yearly Shares OutstandingKIN.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
KIN.BR Yearly Total Debt VS Total AssetsKIN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 1.51, we must say that KIN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.51, KIN is in the better half of the industry, outperforming 64.44% of the companies in the same industry.
KIN has a debt to FCF ratio of 6.27. This is a slightly negative value and a sign of low solvency as KIN would need 6.27 years to pay back of all of its debts.
KIN's Debt to FCF ratio of 6.27 is in line compared to the rest of the industry. KIN outperforms 53.33% of its industry peers.
A Debt/Equity ratio of 2.70 is on the high side and indicates that KIN has dependencies on debt financing.
The Debt to Equity ratio of KIN (2.70) is worse than 71.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.7
Debt/FCF 6.27
Altman-Z 1.51
ROIC/WACC1.35
WACC5.21%
KIN.BR Yearly LT Debt VS Equity VS FCFKIN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.52 indicates that KIN may have some problems paying its short term obligations.
KIN's Current ratio of 0.52 is on the low side compared to the rest of the industry. KIN is outperformed by 75.56% of its industry peers.
A Quick Ratio of 0.49 indicates that KIN may have some problems paying its short term obligations.
KIN has a Quick ratio of 0.49. This is in the lower half of the industry: KIN underperforms 75.56% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.49
KIN.BR Yearly Current Assets VS Current LiabilitesKIN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

4

3. Growth

3.1 Past

KIN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -27.79%.
Measured over the past years, KIN shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.80% on average per year.
Looking at the last year, KIN shows a decrease in Revenue. The Revenue has decreased by -4.51% in the last year.
The Revenue has been growing slightly by 0.95% on average over the past years.
EPS 1Y (TTM)-27.79%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%15.09%
Revenue 1Y (TTM)-4.51%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%4.74%

3.2 Future

The Earnings Per Share is expected to grow by 15.31% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.98% on average over the next years.
EPS Next Y48.8%
EPS Next 2Y31.49%
EPS Next 3Y24.23%
EPS Next 5Y15.31%
Revenue Next Year6.06%
Revenue Next 2Y6.3%
Revenue Next 3Y5.46%
Revenue Next 5Y4.98%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
KIN.BR Yearly Revenue VS EstimatesKIN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
KIN.BR Yearly EPS VS EstimatesKIN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2 3

5

4. Valuation

4.1 Price/Earnings Ratio

KIN is valuated rather expensively with a Price/Earnings ratio of 24.25.
Compared to the rest of the industry, the Price/Earnings ratio of KIN indicates a somewhat cheap valuation: KIN is cheaper than 77.78% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of KIN to the average of the S&P500 Index (27.03), we can say KIN is valued inline with the index average.
The Price/Forward Earnings ratio is 14.29, which indicates a correct valuation of KIN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of KIN indicates a somewhat cheap valuation: KIN is cheaper than 75.56% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.28. KIN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 24.25
Fwd PE 14.29
KIN.BR Price Earnings VS Forward Price EarningsKIN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as KIN.
77.78% of the companies in the same industry are more expensive than KIN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.06
EV/EBITDA 10.06
KIN.BR Per share dataKIN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
KIN's earnings are expected to grow with 24.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y31.49%
EPS Next 3Y24.23%

3

5. Dividend

5.1 Amount

KIN has a Yearly Dividend Yield of 1.06%. Purely for dividend investing, there may be better candidates out there.
KIN's Dividend Yield is a higher than the industry average which is at 2.58.
Compared to an average S&P500 Dividend Yield of 2.40, KIN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.06%

5.2 History

The dividend of KIN decreases each year by -3.32%.
Dividend Growth(5Y)-3.32%
Div Incr Years1
Div Non Decr Years2
KIN.BR Yearly Dividends per shareKIN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

36.36% of the earnings are spent on dividend by KIN. This is a low number and sustainable payout ratio.
DP36.36%
EPS Next 2Y31.49%
EPS Next 3Y24.23%
KIN.BR Yearly Income VS Free CF VS DividendKIN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
KIN.BR Dividend Payout.KIN.BR Dividend Payout, showing the Payout Ratio.KIN.BR Dividend Payout.PayoutRetained Earnings

KINEPOLIS

EBR:KIN (8/5/2025, 7:00:00 PM)

35.65

+0.05 (+0.14%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-20 2025-02-20/amc
Earnings (Next)08-21 2025-08-21
Inst Owners15.64%
Inst Owner ChangeN/A
Ins Owners1.8%
Ins Owner ChangeN/A
Market Cap975.74M
Analysts86
Price Target49.64 (39.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.06%
Yearly Dividend0.54
Dividend Growth(5Y)-3.32%
DP36.36%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.68%
PT rev (3m)-3.95%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.87%
Revenue NY rev (3m)-2.11%
Valuation
Industry RankSector Rank
PE 24.25
Fwd PE 14.29
P/S 1.69
P/FCF 8.06
P/OCF 5.96
P/B 4.32
P/tB 25.04
EV/EBITDA 10.06
EPS(TTM)1.47
EY4.12%
EPS(NY)2.49
Fwd EY7%
FCF(TTM)4.42
FCFY12.4%
OCF(TTM)5.98
OCFY16.77%
SpS21.12
BVpS8.25
TBVpS1.42
PEG (NY)0.5
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.54%
ROE 17.91%
ROCE 9.58%
ROIC 7.04%
ROICexc 7.81%
ROICexgc 10.3%
OM 14.2%
PM (TTM) 7%
GM 24.01%
FCFM 20.93%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
ROICexc(3y)7.02%
ROICexc(5y)N/A
ROICexgc(3y)8.91%
ROICexgc(5y)N/A
ROCE(3y)9.19%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-1%
ROICexc growth 3YN/A
ROICexc growth 5Y-1.69%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
F-Score5
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 2.7
Debt/FCF 6.27
Debt/EBITDA 3.71
Cap/Depr 52.05%
Cap/Sales 7.37%
Interest Coverage 3.53
Cash Conversion 99.8%
Profit Quality 299.1%
Current Ratio 0.52
Quick Ratio 0.49
Altman-Z 1.51
F-Score5
WACC5.21%
ROIC/WACC1.35
Cap/Depr(3y)43.12%
Cap/Depr(5y)41.32%
Cap/Sales(3y)6.29%
Cap/Sales(5y)10.19%
Profit Quality(3y)301.12%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.79%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%15.09%
EPS Next Y48.8%
EPS Next 2Y31.49%
EPS Next 3Y24.23%
EPS Next 5Y15.31%
Revenue 1Y (TTM)-4.51%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%4.74%
Revenue Next Year6.06%
Revenue Next 2Y6.3%
Revenue Next 3Y5.46%
Revenue Next 5Y4.98%
EBIT growth 1Y-22.5%
EBIT growth 3YN/A
EBIT growth 5Y-3.89%
EBIT Next Year112.63%
EBIT Next 3Y32.23%
EBIT Next 5Y22.36%
FCF growth 1Y2.2%
FCF growth 3Y19%
FCF growth 5Y6.53%
OCF growth 1Y5.96%
OCF growth 3Y22.57%
OCF growth 5Y1.63%